COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS
Abstract
Aim. To assess the prognostic value of selected in-hospital lethality prognostic scales in patients with ST segment elevation myocardial infarction (STEMI) and to create a new, original risk scale. Material and methods. The analysis included the data of 800 consecutive patients admitted to the Kemerovo Cardiology Dispanser with STEMI diagnosis in 2008– 2009. The level of in-hospital lethality was 10,5% (84 deaths). Results. The risk stratification at admission with TIMI (after pre-hospital thrombolysis) or GRACE scales, or after angiography with CADILLAC scale, provided an important prognostic information and relatively accurately identified the patients at high risk. However, these scales, created for different clinical groups, demonstrated heterogeneous prognostic value, required information on the levels of coronary artery damage, and were not always applicable to the everyday clinical practice settings. Conclusion. Therefore, a new, original prognostic scale (KemScore) has been created, which is based on clinical parameters and glycaemia levels. Independently of the selected therapeutic strategy, this scale provides a reliable assessment of inhospital lethality risk, and could be used as early as within the first hour after admission.
About the Authors
M. V. Zykov
Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
Russian Federation
Russian Federation
O. L. Barbarash
Kemerovo State Medical Academy, Kemerovo, Russia
Russian Federation
Russian Federation
D. S. Zykova
Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
Russian Federation
Russian Federation
V. N. Karetnikova
Kemerovo State Medical Academy, Kemerovo, Russia
Russian Federation
Russian Federation
E. V. Tavlueva
Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
Russian Federation
Russian Federation
V. V. Kashtalap
Research Institute of Complex Cardiovascular Problems, Siberian Branch, Russian Academy of Medical Sciences, Kemerovo
Russian Federation
Russian Federation
References
1. Peterson E.D., Shaw L.J., Califf R.M. Clinical Guideline: Part II: Risk stratification after myocardial infarction. Ann. Intern. Med. 1997; 126:561–582.
2. Morrow D.A., Antman E.M., Charlesworth A. et al. TIMI risk score for ST-elevation myocardial infarction. A convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for Treatment of infracting Myocardium Early II Trial substudy. Circulation 2000; 102:2031–37.
3. Baptista S.B., Farto e Abreu P., Loureiro J.R. et al. PAMI risk score for mortality prediction in acute myocardial indarction treated with primary angioplasty. Rev. Port. Cardiol 2004; 23 (5):683–693.
4. Halkin A., Singh M., Nikolsky E. et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction. The CADILLAC Risk Score.J. Am. Coll. Cardiol 2005; 45:1397–1405.
5. Grander B.C., Goldberg J.R., Dabbous O. et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch. Intern. Med 2003; 163:2345–53.
6. Lev E.I., Kornowski R., Vaknin-Assa H. et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am.J. Cardiol 2008; 102:6–11.
7. Ishihara M., Kojima S., Sakamoto T., et al. Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol 2009; 104:769–774.
8. Kawano H., Motoyama T., Hirashima O., et al. Hyperglycemia rapidly suppresses flowmediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34:146 –154.
9. Sakamoto T., Ogawa H., Kawano H., et al. Rapid change of platelet aggregability in acute hyperglycemia: detection by a novel laser-light scattering method. Thromb Haemost. 2000; 83:475– 479.
10. Pandolfi A., Giaccari A., Cilli C., et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol. 2001; 38:71–76.
11. Aljada A., Friedman J., Ghanim H., et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 2006; 55:1177–85.
Review
For citations:
Zykov M.V., Barbarash O.L., Zykova D.S., Karetnikova V.N., Tavlueva E.V., Kashtalap V.V. COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS. Russian Journal of Cardiology. 2012;(1):11-16. (In Russ.)
Views:
719
Email this article 